Biopharma leaders react to the forced resignation of CDER Head Peter Marks as RFK Jr.’s promised job cuts begin at the FDA; ...
Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback